Discussions Regarding Exotic Animal Importation, Sale, and Distribution: Summary of Information Presented at Public Meeting, 44698-44699 [E6-12736]
Download as PDF
44698
Federal Register / Vol. 71, No. 151 / Monday, August 7, 2006 / Notices
Federal Communications Commission.
Marlene H. Dortch,
Secretary.
[FR Doc. 06–6757 Filed 8–3–06; 12:40 pm]
BILLING CODE 6712–01–P
FEDERAL HOUSING FINANCE BOARD
Sunshine Act Meeting Notice;
Announcing a Partially Open Meeting
of the Board of Directors
The open meeting of the
Board of Directors is scheduled to begin
at 10 a.m. on Wednesday, August 9,
2006. The closed portion of the meeting
will follow immediately the open
portion of the meeting.
PLACE: Board Room, First Floor, Federal
Housing Finance Board, 1625 Eye
Street, NW., Washington, DC 20006.
STATUS: The first portion of the meeting
will be open to the public. The final
portion of the meeting will be closed to
the public.
TIME AND DATE:
MATTERS TO BE CONSIDERED AT THE OPEN
PORTION: Data Reporting Requirements:
Affordable Housing Program.
Proposed Bank Examination Rating
System.
MATTER TO BE CONSIDERED AT THE CLOSED
PORTION: Periodic Update of
Examination Program Development and
Supervisory Findings.
CONTACT PERSON FOR MORE INFORMATION:
Shelia Willis, Paralegal Specialist,
Office of General Counsel, at 202–408–
2876 or williss@fhfb.gov.
Dated: August 2, 2006.
By the Federal Housing Finance Board.
John P. Kennedy,
General Counsel.
[FR Doc. 06–6748 Filed 8–3–06; 9:33 am]
BILLING CODE 6725–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Government-Owned Inventions:
Availability for Licensing
National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention.
Technology Transfer Office, Department
of Health and Human Services.
ACTION: Notice.
sroberts on PROD1PC70 with NOTICES
AGENCY:
SUMMARY: The invention named in this
notice is owned by agencies of the
United States Government and is
available for licensing in the United
VerDate Aug<31>2005
17:19 Aug 04, 2006
Jkt 208001
States (U.S.) in accordance with 35
U.S.C. 207, to achieve expeditious
commercialization of results of federally
funded research and development. This
opportunity is available until 30 days
after publication of this notice.
Respondents may be provided a longer
period of time to furnish additional
information if CDC/NIOSH finds this
necessary.
Licensing information may
be obtained by contacting Thomas
O’Toole, Chief Licensing Officer,
Technology Transfer Office, Centers for
Disease Control and Prevention (CDC),
Mailstop K–79, 4770 Buford Highway,
Atlanta, GA 30341, telephone (770)
488–8600; facsimile (770) 488–8615.
Information related to the listed
technology, may be obtained by
contacting Eric Zahl, Civil Engineer,
Spokane Research Laboratory, National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC), 315 E.
Montgomery Avenue, Spokane, WA
99207, telephone (509) 354–8020; or email EZahl@cdc.gov.
Occupational Safety Device—Mobile
Manipulator System (MMS): NIOSH
researchers have developed a Mobile
Manipulator System (MMS), a prototype
lifting device that enables one person to
lift and maneuver up to 600 pound
loads. The MMS is a utility device,
designed to reduce lifting accidents
among maintenance personnel
associated with the manual handling of
equipment and materials. Prototype
specifications, capabilities, photos,
video clips, and further details may be
viewed online at https://www.cdc.gov/
niosh/mining/products/product147.htm.
CDC/NIOSH is seeking licensing
partner(s) to refine development of this
system and commercialize the final
product. Preferred partners should have
a strong market share and a
demonstrated business network capable
of effective dissemination and customer
support for the final product. Partners
should also have: (1) Expertise in
developing safe and effective material
handling equipment for the U.S.
markets and (2) evidence of
manufacturing similar types of
equipment for wide-spread distribution
throughout U.S. markets in an
expeditious manner.
Companies interested in the
opportunity should submit a proposal of
five pages or less to: Eric Zahl, Civil
Engineer, Spokane Research Laboratory,
National Institute for Occupational
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC),
315 E. Montgomery Avenue, Spokane,
ADDRESSES:
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
WA 99207, telephone (509) 354–8020;
or e-mail EZahl@cdc.gov.
Inventors: Clark, Curtis.
U.S. Patent Application SN: 10/485,706
filed 2/2/2004 and PCT/US02/24542.
(CDC Ref. #: I–018–01 & I–029–05)
Dated: July 31, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–12734 Filed 8–4–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Discussions Regarding Exotic Animal
Importation, Sale, and Distribution:
Summary of Information Presented at
Public Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
ACTION: Notice; Summary of information
presented at public meeting.
AGENCY:
SUMMARY: On May 18, 2006, CDC hosted
a public meeting on the subject of
infectious disease threats associated
with exotic animal importation and
trade. CDC announced the public
meeting through a Federal Register
notice on April 20, 2006 (Volume 71,
Number 76, Page 20402–20403). The
public meeting was held at 130
Clairemont Ave., Decatur, GA 30030,
from 1 p.m. to 5 p.m.
Background: Zoonoses are diseases
that can be transmitted from animals to
people. Wild exotic animals may carry
a variety of known and emerging
zoonotic pathogens. The American
Veterinary Medical Association
(AVMA), the Council of State and
Territorial Epidemiologists (CSTE), and
the National Association of State Public
Health Veterinarians (NASPHV) have
issued position statements calling for a
coordinated federal approach to better
control infectious disease risks
associated with the exotic animal trade.
To gather information on the topic, CDC
organized this public meeting to share
information concerning infectious
disease risks associated with exotic
animal importation and trade.
Meeting Summary: Five panelists
were present to answer potential
questions generated by public
comments; these panelists represented
NASPHV, HHS/CDC, the United States
Department of Agriculture (USDA)
Animal and Plant Health Inspection
Service (APHIS) Animal Care, HHS/
E:\FR\FM\07AUN1.SGM
07AUN1
sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 71, No. 151 / Monday, August 7, 2006 / Notices
Food and Drug Administration (FDA),
and the Department of the Interior (DOI)
United States Fish and Wildlife Service
(FWS). No questions or comments were
posed to the panel during the public
meeting.
A representative from HHS/CDC’s
Division of Global Migration and
Quarantine provided an overview of the
scope of the current issues and
problems surrounding exotic animal
importation and the spread of disease.
Reasons for concern include a highvolume trade with rapid turnover of
animals and the absence of health
screening for animals prior to or after
shipment. The meeting was opened by
inviting comments and discussion
regarding the exotic pet trade and
associated infectious disease risks. The
meeting facilitator addressed the time
limits for speakers to a maximum of 15
minutes and reminded attendees that
the discussion would be a matter of
public record.
Two registered participants addressed
the panel and meeting attendees. A
representative of the Consortium for
Conservation at Wildlife Trust, New
York, read a statement describing the
work of the Consortium on exotic
animal importation with two primary
research objectives: (1) to catalog the
wildlife species that are legally
imported to the United States each year
and assess the risk of this trade
introducing pathogens into the United
States; and (2) to work with wildlife
dealers to understand how the process
of importation influences the risk of
disease emergence. The Consortium
hopes the findings of this scientific
initiative will be used to make policy
recommendations on disease screening
for imported wild animals that will
maintain the economic and other
benefits of the trade while minimizing
risks for introducing new diseases.
A representative of PETCO Animal
Supplies read a statement indicating
that PETCO opposes a possible ban on
the importation of exotic animals and
fully supports legal importation when
proper biosecurity measures are taken to
ensure the public health. Details of
PETCO’s current activities for ensuring
animal and owner health and safety
were presented. The representative from
PETCO also stated that PETCO feels the
legal trade of exotic animals has a
positive economic effect on captive
breeding and export programs in other
countries by supporting the local
economy and curbing poaching of
animals from their native habitats.
After the registered participants read
their prepared statements, 20 public
comments that had been received prior
to the meeting by e-mail and fax were
VerDate Aug<31>2005
17:19 Aug 04, 2006
Jkt 208001
read into the public record. Public
comments submitted prior to the
meeting included the following:
• Two requests from avian groups
(representative of the Indonesian Parrot
Project and a representative from the
Avian Welfare Coalition) were
submitted requesting that importation of
all wild birds be banned except for
legitimate scientific purposes. In
addition, these statements suggested the
risk of zoonoses from birds within the
United States could be reduced through
mandatory quarantine and laboratory
testing of birds for interstate transport,
enforcing bans on animal fighting,
requiring a permit system for
commercial sale of birds, and
establishing strict biosecurity
procedures for avian care facilities.
• A statement was submitted by a
representative from the Captive Wild
Animal Protection Coalition requesting
a ban of all importation of exotic
animals for private ownership, revising
legislation to prevent commercial sale of
wildlife, forming a single regulatory
agency to oversee the exotic animal
trade, introducing biosecurity measures
to reduce disease risks from wild
animals, prohibiting further breeding of
wild or exotic animals by private
individuals, prohibiting the trade or
movement of wild/exotic animals
already in private hands, and
introducing a new licensing system to
ensure that wild/exotic animals held by
private individuals are registered.
• A statement from a private citizen
was submitted opposing all exotic
animal importation.
• A statement was submitted from a
representative of the Conservator’s
Center, Inc. opposing actions to prevent
organizations that are not members of
the Association of Zoos and Aquariums
(AZA) from participating in wild/exotic
animal ownership. This statement
indicated that private sector expertise
was needed to facilitate protection of
endangered species. This statement
requested that any standards imposed
on owners or importers be science-based
and not influenced by politics or media
attention.
• A statement was submitted from a
representative of Big Cat Rescue
requesting a prohibition on the trade of
exotic cats due to public safety and
disease concerns.
• A statement was submitted from a
representative of the Idaho State
Department of Agriculture supporting a
comprehensive system to restrict
importation of any exotic plants and
animals, and to allow entry only after
appropriate testing and quarantine.
• A statement was submitted from an
owner of a pet monkey stating she
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
44699
believes all pet monkeys in private
ownership were born in the United
States, and that she does not believe
there has been any transfer of disease
from pet monkeys to owners in the past
20 years.
• A statement was submitted from a
member of the Society for Small
Nonintrusive Government stating that
they support a complete ban on exotic
animal importation and native wildlife
export. This statement indicated an
opposition to any federal regulation of
exotic animal trade inside the U.S.
borders, indicating it is a matter best
regulated by individual states.
• A statement was submitted from a
citizen indicating they felt that claims
regarding infectious disease risks from
exotic animals were over-exaggerated.
• Five statements were submitted
from citizens suggesting that typical
domestic pets carry a disease risk
similar to that of exotic animals, and
that living with pets is beneficial to
humans. These statements indicated
that exotic animals should be
categorized in the same manner as
domestic pets, and that proper
husbandry and handwashing are
common-sense approaches to reduce
disease risks.
• Three statements were submitted
from citizens indicating that ferrets are
domestic species and should not be
restricted.
• A statement was submitted from a
citizen opposing removal of exotic
animals from the commercial pet trade
and indicating that better regulations,
inspections, and oversight would be a
more appropriate response.
• A statement was submitted from a
citizen claiming that legislation of the
exotic animal trade is best left to
individual states, and opposing any
more federal legislation on animal
importation.
In summary, a variety of positions and
views were submitted to the public
meeting. Of the 22 statements received
for consideration, 7 indicated a measure
of support for increased restrictions on
the importation and sale of exotic
species, while 15 expressed support for
alternatives to regulatory or legal
restrictions or opposition to possible
restrictions.
Dated: July 30, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–12736 Filed 8–4–06; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\07AUN1.SGM
07AUN1
Agencies
[Federal Register Volume 71, Number 151 (Monday, August 7, 2006)]
[Notices]
[Pages 44698-44699]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-12736]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Discussions Regarding Exotic Animal Importation, Sale, and
Distribution: Summary of Information Presented at Public Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice; Summary of information presented at public meeting.
-----------------------------------------------------------------------
SUMMARY: On May 18, 2006, CDC hosted a public meeting on the subject of
infectious disease threats associated with exotic animal importation
and trade. CDC announced the public meeting through a Federal Register
notice on April 20, 2006 (Volume 71, Number 76, Page 20402-20403). The
public meeting was held at 130 Clairemont Ave., Decatur, GA 30030, from
1 p.m. to 5 p.m.
Background: Zoonoses are diseases that can be transmitted from
animals to people. Wild exotic animals may carry a variety of known and
emerging zoonotic pathogens. The American Veterinary Medical
Association (AVMA), the Council of State and Territorial
Epidemiologists (CSTE), and the National Association of State Public
Health Veterinarians (NASPHV) have issued position statements calling
for a coordinated federal approach to better control infectious disease
risks associated with the exotic animal trade. To gather information on
the topic, CDC organized this public meeting to share information
concerning infectious disease risks associated with exotic animal
importation and trade.
Meeting Summary: Five panelists were present to answer potential
questions generated by public comments; these panelists represented
NASPHV, HHS/CDC, the United States Department of Agriculture (USDA)
Animal and Plant Health Inspection Service (APHIS) Animal Care, HHS/
[[Page 44699]]
Food and Drug Administration (FDA), and the Department of the Interior
(DOI) United States Fish and Wildlife Service (FWS). No questions or
comments were posed to the panel during the public meeting.
A representative from HHS/CDC's Division of Global Migration and
Quarantine provided an overview of the scope of the current issues and
problems surrounding exotic animal importation and the spread of
disease. Reasons for concern include a high-volume trade with rapid
turnover of animals and the absence of health screening for animals
prior to or after shipment. The meeting was opened by inviting comments
and discussion regarding the exotic pet trade and associated infectious
disease risks. The meeting facilitator addressed the time limits for
speakers to a maximum of 15 minutes and reminded attendees that the
discussion would be a matter of public record.
Two registered participants addressed the panel and meeting
attendees. A representative of the Consortium for Conservation at
Wildlife Trust, New York, read a statement describing the work of the
Consortium on exotic animal importation with two primary research
objectives: (1) to catalog the wildlife species that are legally
imported to the United States each year and assess the risk of this
trade introducing pathogens into the United States; and (2) to work
with wildlife dealers to understand how the process of importation
influences the risk of disease emergence. The Consortium hopes the
findings of this scientific initiative will be used to make policy
recommendations on disease screening for imported wild animals that
will maintain the economic and other benefits of the trade while
minimizing risks for introducing new diseases.
A representative of PETCO Animal Supplies read a statement
indicating that PETCO opposes a possible ban on the importation of
exotic animals and fully supports legal importation when proper
biosecurity measures are taken to ensure the public health. Details of
PETCO's current activities for ensuring animal and owner health and
safety were presented. The representative from PETCO also stated that
PETCO feels the legal trade of exotic animals has a positive economic
effect on captive breeding and export programs in other countries by
supporting the local economy and curbing poaching of animals from their
native habitats.
After the registered participants read their prepared statements,
20 public comments that had been received prior to the meeting by e-
mail and fax were read into the public record. Public comments
submitted prior to the meeting included the following:
Two requests from avian groups (representative of the
Indonesian Parrot Project and a representative from the Avian Welfare
Coalition) were submitted requesting that importation of all wild birds
be banned except for legitimate scientific purposes. In addition, these
statements suggested the risk of zoonoses from birds within the United
States could be reduced through mandatory quarantine and laboratory
testing of birds for interstate transport, enforcing bans on animal
fighting, requiring a permit system for commercial sale of birds, and
establishing strict biosecurity procedures for avian care facilities.
A statement was submitted by a representative from the
Captive Wild Animal Protection Coalition requesting a ban of all
importation of exotic animals for private ownership, revising
legislation to prevent commercial sale of wildlife, forming a single
regulatory agency to oversee the exotic animal trade, introducing
biosecurity measures to reduce disease risks from wild animals,
prohibiting further breeding of wild or exotic animals by private
individuals, prohibiting the trade or movement of wild/exotic animals
already in private hands, and introducing a new licensing system to
ensure that wild/exotic animals held by private individuals are
registered.
A statement from a private citizen was submitted opposing
all exotic animal importation.
A statement was submitted from a representative of the
Conservator's Center, Inc. opposing actions to prevent organizations
that are not members of the Association of Zoos and Aquariums (AZA)
from participating in wild/exotic animal ownership. This statement
indicated that private sector expertise was needed to facilitate
protection of endangered species. This statement requested that any
standards imposed on owners or importers be science-based and not
influenced by politics or media attention.
A statement was submitted from a representative of Big Cat
Rescue requesting a prohibition on the trade of exotic cats due to
public safety and disease concerns.
A statement was submitted from a representative of the
Idaho State Department of Agriculture supporting a comprehensive system
to restrict importation of any exotic plants and animals, and to allow
entry only after appropriate testing and quarantine.
A statement was submitted from an owner of a pet monkey
stating she believes all pet monkeys in private ownership were born in
the United States, and that she does not believe there has been any
transfer of disease from pet monkeys to owners in the past 20 years.
A statement was submitted from a member of the Society for
Small Nonintrusive Government stating that they support a complete ban
on exotic animal importation and native wildlife export. This statement
indicated an opposition to any federal regulation of exotic animal
trade inside the U.S. borders, indicating it is a matter best regulated
by individual states.
A statement was submitted from a citizen indicating they
felt that claims regarding infectious disease risks from exotic animals
were over-exaggerated.
Five statements were submitted from citizens suggesting
that typical domestic pets carry a disease risk similar to that of
exotic animals, and that living with pets is beneficial to humans.
These statements indicated that exotic animals should be categorized in
the same manner as domestic pets, and that proper husbandry and
handwashing are common-sense approaches to reduce disease risks.
Three statements were submitted from citizens indicating
that ferrets are domestic species and should not be restricted.
A statement was submitted from a citizen opposing removal
of exotic animals from the commercial pet trade and indicating that
better regulations, inspections, and oversight would be a more
appropriate response.
A statement was submitted from a citizen claiming that
legislation of the exotic animal trade is best left to individual
states, and opposing any more federal legislation on animal
importation.
In summary, a variety of positions and views were submitted to the
public meeting. Of the 22 statements received for consideration, 7
indicated a measure of support for increased restrictions on the
importation and sale of exotic species, while 15 expressed support for
alternatives to regulatory or legal restrictions or opposition to
possible restrictions.
Dated: July 30, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E6-12736 Filed 8-4-06; 8:45 am]
BILLING CODE 4163-18-P